DeFi Lens builds advanced Generative AI for Technical Analysis
NEW YORK, April 23, 2024 /CNW/ -- In the dynamic world of decentralized finance (DeFi), staying ahead of the curve and maintaining a competitive edge is crucial. Today, it is thrilling to announce the launch of DeFi Lens (https://defilens.ai) ? an innovative AI platform combining generative AI and Web3 trustworthy proofs to equip traders, especially those using technical analysis (TA) strategies, and crypto enthusiasts with better market signals and insights. DeFi Lens transforms how traders or crypto users search for alphas, exchange signals & data, and analyze trading strategies. The project is incubated by Oraichain Labs.
Revolutionizing Crypto Analysis with AI
DeFi Lens combines popular analytics tools in the crypto market and the power of generative AI. DeFi Lens is a fusion of AI and Web3 to approach real-time market intelligence to facilitate a Web3 future that is more efficient, and accessible than ever before.
DeFi Lens has its key features to compete with other crypto tools in the market:
AI Explainer: helps traders understand crypto chart patterns, technical analysis, crypto predictions, data reports, and recommendations.
AI Positions: optimizes strategy parameters to identify profitable trading strategies and generate trading signals based on historical data. With thousands of cryptocurrencies in the market, numerous signals, and trading strategies, real-time analysis, DeFi Lens aims to solve significant computational challenges with AI-powered automation.
Mass Backtesting of Technical Analysis: candlestick patterns, chart indicators, trend following, volume profile, Wyckoff-based VSA/VPA. Signals and strategies are algorithmically verified, with results stored on the blockchain via the Trustworthy Proofs contracts, making crypto trading verifiable.
Customizable Alpha Search: 31+ preference settings to conduct alpha search. No-code AI, using natural language to search, is soon available.
Join the DeFi Lens revolution
DeFi Lens launched its FREE public beta this April and is now available at https://defilens.ai. Explore this groundbreaking tool now, connect with its vibrant community, and take crypto journeys to new heights.
About DeFi Lens
Incubated by Labs, DeFi Lens is an AI crypto tool with customizable and generative power to transform how traders or crypto users search for alphas, exchange signals, and analyze trading strategies. Signals and strategies are subject to monetary values and follow a Trustworthy Proofs protocol.
About Oraichain
Oraichain (https://orai.io) provides multidimensional trustworthy proofs of AI and enables secure integration with Web3. Oraichain is the world's first layer 1 of AI oracle.
Helius Medical Technologies, Inc. ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced results for the quarter ended March 31, 2024. First...
Harrow , a leading North American eyecare pharmaceutical company, announced results for the first quarter ended March 31, 2024. The Company also posted its first quarter Letter to Stockholders and corporate presentation to the "Investors" section of...
CVD Equipment Corporation , today announced its financial results for the first quarter ended March 31, 2024.
Manny Lakios, President and CEO of CVD Equipment Corporation, commented, "First quarter 2024 revenue was $4.9 million, down significantly...
Spruce Biosciences, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today reported financial results for the first quarter ended...
Dundee Corporation ("Dundee") announced today that its board of directors has approved the payment of a quarterly cash dividend of $0.33025 per cumulative 5-year rate reset first preference share, series 2 payable on July 2, 2024 to shareholders of...
Dundee Corporation ("Dundee") announced today that its board of directors has approved the payment of a quarterly cash dividend of $0.56595 per cumulative floating rate first preference share, series 3 payable on July 2, 2024 to shareholders of...